12th Annual Meeting of the American Society of Gene Therapy

May 29, 2009
Plenary Abstract Session 330
Presentation of Top Abstracts
3:45 pm – 5:45 pm

PRESENTATION RATINGS

Presenter/Topic	Overall Rating
	Excellent	Good	Average	Poor	Very Poor
426. Jean Bennett - Gene Therapy-Mediated Reversal of Congenital Blindness: Demonstration of Efficacy in a Phase 1 Safety Trial
427. Nelson C. Di Paolo - The Interaction of Adenovirus with the beta-3 Integrin Mediates the Activation of IL-1alpha, a Key Cytokine That Triggers the Immediate Pro-Inflammatory Macrophage Response In Vivo
428. Tatiana Segura - Clustered Ligands Enhance Targeting of Polyethyleneimine Vectors In Vivo
429. Shin-ichi Muramatsu - Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson’s Disease: Results from an Open-Label, Phase I Trial
430. Angelo Lombardo - Characterization of Potential Genomic “Safe Harbor” for Efficient Targeted Gene Addition with Zinc Finger Nucleases
431. Catherine M. Bollard - Complete Tumor Responses in Lymphoma Patients Who Receive Tumor-Specific Cytotoxic T Lymphocytes Generated Using Genetically Modified Antigen Presenting Cells

Rate the scientific level of the presentation	Too Basic	Appropriate	Too Advanced
Was the presentation fair, balanced and free from commercial bias?	Yes	No

If the answer to question 433 is no, please explain.
Other Comments and Suggestions: